Virtual Medicinal Product (VMP)
-
Dopexamine 50mg/5ml solution for infusion ampoules
Name Details
Current Name
Dopexamine 50mg/5ml solution for infusion ampoules
|
Start Date
16-01-2009
|
End Date
|
Previous Name
Dopexamine 50mg/5ml solution for injection ampoules
|
Start Date
16-06-2004
|
End Date
15-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
C01CA14
BNF |
Current BNF
02070100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
02070100
|
Start Date
09-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36071111000001103 |
30-10-2018 |
|
319543004 |
18-08-2003 |
29-10-2018 |
VMP Ingredients
Name
Dopexamine hydrochloride
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Dopexamine
-
VMP
(Current) Dopexamine 50mg/5ml solution for inf...
Virtual Medicinal Product Pack (VMPP) Information